Provided by Tiger Fintech (Singapore) Pte. Ltd.

JUNSHI BIO

26.580
+0.2801.06%
Volume:614.60K
Turnover:16.05M
Market Cap:27.30B
PE:-18.67
High:26.600
Open:26.080
Low:25.820
Close:26.300
52wk High:38.640
52wk Low:10.180
Shares:1.03B
HK Float Shares:260.00M
Volume Ratio:1.43
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.424
ROE:-16.95%
ROA:-5.60%
PB:4.01
PE(LYR):-18.67
PS:10.04

Loading ...

Shanghai Junshi Biosciences (Stock Code: 1877, 688180) Announces 2025 Third Quarterly Results Briefing

Bulletin Express
·
Oct 21

Junshi Biosciences Gets US FDA's Nod for Phase II/III Trial of Lung Cancer Drug

MT Newswires Live
·
Oct 17

HK Movers | Biomedical Stocks Jump Again With TransThera Sciences up 30%

Tiger Newspress
·
Oct 17

Hong Kong Stocks Move | JUNSHI BIO (01877) Opens Nearly 5% Higher After FDA Approval for JS207 Related Phase II/III Clinical Trial Application

Stock News
·
Oct 17

BRIEF-Shanghai Junshi Biosciences Receives FDA Approval Of Investigational New Drug Application For Phase II/III Clinical Study Of JS207

Reuters
·
Oct 16

Shanghai Junshi Biosciences - FDA Approval of Investigational New Drug Application for Phase Ii/Iii Clinical Study of Js207

THOMSON REUTERS
·
Oct 16

Analysis of Stock Holdings in Hong Kong Connect | October 16

Stock News
·
Oct 16

Hong Kong Stock Connect Holdings Analysis for October 15

Stock News
·
Oct 15

HK Movers | Biomedical Stocks Decline With Junshi Biosciences Down 8%

Tiger Newspress
·
Oct 13

JUNSHI BIO (01877): Share Increase Plan More Than Halfway Through, Chairman Xiong Jun Has Not Yet Increased Holdings

Stock News
·
Oct 10

Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Could Be 29% Below Their Intrinsic Value Estimate

Simply Wall St.
·
Oct 06

JUNSHI BIO (01877) Subsidiary Juntuo Bio Invests 80 Million Yuan in Beijing Sand Biotechnology

Stock News
·
Sep 29

JUNSHI BIO (01877) Appoints Yang Jin as Independent Non-Executive Director

Stock News
·
Sep 29

HK Movers | Biotech Shares Soar. Junshi Bio, JOINN, RemeGen up 6%; Asymchem, Hengrui Pharma up 3%

Tiger Newspress
·
Sep 25

Hong Kong Stocks Movement | JUNSHI BIO (01877) Surges Over 6% as More Than 20 Studies Including Toripalimab Set to Be Presented at ESMO 2025 Conference

Stock News
·
Sep 25

Has Junshi’s 200% Rally Priced in the Latest Immunotherapy Breakthrough?

Simply Wall St.
·
Sep 14

Hong Kong Stocks Movement | JUNSHI BIO (01877) Surges Over 9% as JS005 Achieves Positive Results in Phase III Clinical Trial for Moderate to Severe Plaque Psoriasis

Stock News
·
Sep 09

Hong Kong Stocks End in Green; Junshi Bio Gains 3%

MT Newswires Live
·
Sep 08

Junshi Biosciences' Dermatology Drug JS005 Meets Goal in Phase 3 Study

MT Newswires Live
·
Sep 08

HK Movers|Pharma Stocks Jumped. 3S Bio up 15%; Laekna up 8%; Junshi up 7%; HBM, SKB Bio and TigerMed up 6%.

Tiger Newspress
·
Sep 05